KBO Systems jobs and careers

About KBO Systems

Brain complications during and after surgery cost the U.S. an estimated $82 billion a year. Existing monitors haven't solved it, in part because they generate no billable revenue for the provider. Adoption has stayed below 20% for decades. KBO changes that. We combine multi-region EEG, auditory evoked potentials, and proprietary machine learning to monitor the brain across the full surgical journey: — Pre-op: cognitive vulnerability screening before anesthesia — Intra-op: real-time, drug-aware depth monitoring — Post-op: delirium detection and brain recovery tracking Our outputs are designed to align with existing CPT reimbursement codes, shifting brain monitoring from absorbed cost toward a revenue-generating workflow. Validated at UC Davis Health and McLeod Health. Science independently validated by MIT. Patents pending. FDA 510(k) in progress.

Founded in 2021 by Kevin Goehl, Rocky Cagle and Stephen Hatch.